No Data
Express News | Watching Petros Pharmaceuticals; Shares Trading Higher, Company Files Amended S-1 Filing
Petros Pharmaceuticals Files to Sell Units, No Amount Given
Retros Pharmaceuticals Shares Are Trading Higher After the Company Announced It's in a Position to Lead the Rx-To-OTC Switch Market With Its Proprietary AI and Quantum Computing Platform.
Express News | Petros Pharmaceuticals Positioned To Lead Rx-To-OTC Switch Market With Proprietary AI And Quantum Computing Platform Following FDA Approval Of New ACNU Rule; Aims To Expand Consumer Access Through Innovative Self-Care Solutions
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader From Newly Approved FDA OTC Final Rules
Maxim Group Keeps Their Buy Rating on Petros Pharmaceuticals (PTPI)
